Through our quantitative proteomics analysis of HSPCs from patients with MDS compared with those of healthy controls, we discovered that the FBXO11-NPM1 interactome was profoundly perturbed in MDS. The gene discussed is FBXO11; the disease is myelodysplastic syndrome.